These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 33592139)
1. Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population. Kim HC; Ji W; Lee JC; Kim HR; Song SY; Choi CM; ; Cancer Res Treat; 2021 Oct; 53(4):1033-1041. PubMed ID: 33592139 [TBL] [Abstract][Full Text] [Related]
2. Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery. Yang KL; Chang YC; Ko HL; Chi MS; Wang HE; Hsu PS; Lin CC; Yeh DY; Kao SJ; Jiang JS; Chi KH Clin Lung Cancer; 2016 Nov; 17(6):550-557. PubMed ID: 27378175 [TBL] [Abstract][Full Text] [Related]
3. Treatment patterns and overall survival among patients with unresectable, stage III non-small-cell lung cancer. Bobbili P; Ryan K; Duh MS; Dua A; Fernandes AW; Pavilack M; Gomez JE Future Oncol; 2019 Oct; 15(29):3381-3393. PubMed ID: 31544510 [No Abstract] [Full Text] [Related]
8. Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer? Collaud S; Provost B; Besse B; Fabre D; Le Chevalier T; Mercier O; Mussot S; Fadel E J Surg Oncol; 2018 Jun; 117(7):1570-1574. PubMed ID: 29573419 [TBL] [Abstract][Full Text] [Related]
9. Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non-small cell lung cancer: Updated follow-up results from two phase II trials. Honglian M; Zhouguang H; Fang P; Lujun Z; Dongming L; Yujin X; Yong B; Liming X; Yirui Z; Xiao H; Jin W; Yue K; Lvhua W; Ming C Thorac Cancer; 2020 Apr; 11(4):898-906. PubMed ID: 32068962 [TBL] [Abstract][Full Text] [Related]
10. Survival disparities following surgery among patients with different histological types of non-small cell lung cancer. Grosu HB; Manzanera A; Shivakumar S; Sun S; Noguras Gonzalez G; Ost DE Lung Cancer; 2020 Feb; 140():55-58. PubMed ID: 31865279 [TBL] [Abstract][Full Text] [Related]
11. Long-term survival trends in patients with unresectable stage III non-small cell lung cancer receiving chemotherapy and radiation therapy: a SEER cancer registry analysis. Hansen RN; Zhang Y; Seal B; Ryan K; Yong C; Darilay A; Ramsey SD BMC Cancer; 2020 Apr; 20(1):276. PubMed ID: 32248816 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and outcome of surgically treated patients with brain metastases of non-small cell lung cancer. She C; Wang R; Lu C; Sun Z; Li P; Yin Q; Liu Q; Wang P; Li W Thorac Cancer; 2019 Feb; 10(2):137-142. PubMed ID: 30485664 [TBL] [Abstract][Full Text] [Related]
13. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815 [TBL] [Abstract][Full Text] [Related]
14. Induction chemoimmunotherapy with surgery versus concurrent chemoradiation followed by immunotherapy for stage III-N2 non-small cell lung cancer. Kumar A; Srinivasan D; Potter AL; Mathey-Andrews C; Lanuti M; Martin LW; Jeffrey Yang CF J Thorac Cardiovasc Surg; 2024 Jun; 167(6):1895-1905.e2. PubMed ID: 37722622 [TBL] [Abstract][Full Text] [Related]
15. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer. Gao SJ; Corso CD; Wang EH; Blasberg JD; Detterbeck FC; Boffa DJ; Decker RH; Kim AW J Thorac Oncol; 2017 Feb; 12(2):314-322. PubMed ID: 27720827 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society). Couñago F; Montemuiño S; Martin M; Taboada B; Calvo-Crespo P; Samper-Ots MP; Alcántara P; Corona J; López-Guerra JL; Murcia-Mejía M; López-Mata M; Jové-Teixidó J; Chust M; Díaz-Díaz V; de Ingunza-Barón L; García-Cañibano T; Couselo ML; Del Cerro E; Moradiellos J; Amor S; Varela A; Puertas MM; Thuissard IJ; Sanz-Rosa D; de Dios NR Clin Transl Oncol; 2019 Jun; 21(6):735-744. PubMed ID: 30430394 [TBL] [Abstract][Full Text] [Related]
17. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer. Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696 [TBL] [Abstract][Full Text] [Related]